{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T08:24:26Z","timestamp":1787127866743,"version":"build-2736575974"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T00:00:00Z","timestamp":1783814400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Preventive Medicine Reports"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.pmedr.2026.103571","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T23:08:55Z","timestamp":1783984135000},"page":"103571","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Two-hour glucose reductions and baseline levels for effective prevention of type 2 diabetes in individuals with impaired glucose tolerance: An evidence synthesis and meta-regression analysis"],"prefix":"10.1016","volume":"69","author":[{"given":"Kotoba","family":"Okuyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Tsutsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitaka","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pmedr.2026.103571_bb0005","doi-asserted-by":"crossref","unstructured":"American Diabetes Association Professional Practice Committee for Diabetes, 2026. 2. Diagnosis and classification of diabetes: standards of care in diabetes-2026. Diabetes Care 49 Suppl 1, S27\u2013S49.","DOI":"10.2337\/dc26-S002"},{"key":"10.1016\/j.pmedr.2026.103571_bb0010","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1294819","article-title":"Early effective intervention can significantly reduce all-cause mortality in prediabetic patients: a systematic review and meta-analysis based on high-quality clinical studies","volume":"15","author":"An","year":"2024","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.pmedr.2026.103571_bb0015","series-title":"Introduction to meta-Analysis","author":"Borenstein","year":"2009"},{"issue":"6","key":"10.1016\/j.pmedr.2026.103571_bb0020","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s001250051211","article-title":"Is fasting glucose sufficient to define diabetes? Epidemiological data from 20 European studies","volume":"42","author":"DECODE Study Group","year":"1999","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.pmedr.2026.103571_bb0025","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/archinte.161.3.397","article-title":"Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria","volume":"161","author":"DECODE Study Group","year":"2001","journal-title":"Arch. Intern. Med."},{"issue":"1","key":"10.1016\/j.pmedr.2026.103571_bb0030","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/ndt\/gfaf177","article-title":"IDF diabetes atlas 11th edition 2025: global prevalence and projections for 2050","volume":"41","author":"Duncan","year":"2025","journal-title":"Nephrol. Dial. Transplant."},{"issue":"4","key":"10.1016\/j.pmedr.2026.103571_bb0035","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/eurpub\/ckw085","article-title":"Prevalence of impaired glucose regulation in Europe: a meta-analysis","volume":"26","author":"Eades","year":"2016","journal-title":"Eur. J. Public Health"},{"key":"10.1016\/j.pmedr.2026.103571_bb0040","article-title":"Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis","volume":"355","author":"Huang","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.pmedr.2026.103571_bb0045","series-title":"Cost-Effective Solutions for the Prevention of Type 2 Diabetes","author":"International Diabetes Federation","year":"2016"},{"issue":"3","key":"10.1016\/j.pmedr.2026.103571_bb0050","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0168-8227(00)00187-X","article-title":"Correlation among fasting plasma glucose, two-hour plasma glucose levels in OGTT and HbA1c","volume":"50","author":"Ito","year":"2000","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"Pt 1","key":"10.1016\/j.pmedr.2026.103571_bb0055","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1177\/000456329803500107","article-title":"The reproducibility and usefulness of the oral glucose tolerance test in screening for diabetes and other cardiovascular risk factors","volume":"35","author":"Ko","year":"1998","journal-title":"Ann. Clin. Biochem."},{"issue":"11","key":"10.1016\/j.pmedr.2026.103571_bb0060","doi-asserted-by":"crossref","first-page":"4231","DOI":"10.1210\/jc.2008-0801","article-title":"Reproducibility of the Oral glucose tolerance test in overweight children","volume":"93","author":"Libman","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"10.1016\/j.pmedr.2026.103571_bb0065","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.2337\/dc18-1390","article-title":"Predictive value of fasting glucose, Postload glucose, and hemoglobin A1c on risk of diabetes and complications in Chinese adults","volume":"42","author":"Lu","year":"2019","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.pmedr.2026.103571_bb0070","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/BF00418345","article-title":"Intra-individual variation of glucose, specific insulin and proinsulin concentrations measured by two oral glucose tolerance tests in a general Caucasian population: the Hoorn study","volume":"39","author":"Mooy","year":"1996","journal-title":"Diabetologia"},{"issue":"6","key":"10.1016\/j.pmedr.2026.103571_bb0075","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.amjmed.2008.02.026","article-title":"Normal fasting plasma glucose and risk of type 2 diabetes diagnosis","volume":"121","author":"Nichols","year":"2008","journal-title":"Am. J. Med."},{"issue":"5","key":"10.1016\/j.pmedr.2026.103571_bb0080","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1530\/EJE-15-1221","article-title":"Follow-up duration influences the relative importance of OGTT and optimal timing of glucose measurements for predicting future type 2 diabetes","volume":"174","author":"Nielsen","year":"2016","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.pmedr.2026.103571_bb0085","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d7163","article-title":"Risk models and scores for type 2 diabetes: systematic review","volume":"343","author":"Noble","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.pmedr.2026.103571_bb0090","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2026","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.pmedr.2026.103571_bb0095","doi-asserted-by":"crossref","first-page":"391","DOI":"10.25259\/IJMR_1617_2024","article-title":"Global strategies for preventing type 2 diabetes: a public health perspective","volume":"160","author":"Pappachan","year":"2024","journal-title":"Indian J. Med. Res."},{"issue":"5","key":"10.1016\/j.pmedr.2026.103571_bb0100","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.cct.2008.06.002","article-title":"Estimating the relative hazard by the ratio of logarithms of event-free proportions","volume":"29","author":"Perneger","year":"2008","journal-title":"Contemp. Clin. Trials"},{"issue":"8","key":"10.1016\/j.pmedr.2026.103571_bb0105","first-page":"1961","article-title":"Impaired glucose tolerance and impaired fasting glucose","volume":"69","author":"Rao","year":"2004","journal-title":"Am. Fam. Physician"},{"issue":"10","key":"10.1016\/j.pmedr.2026.103571_bb0110","first-page":"CD012661","article-title":"Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia","volume":"10","author":"Richter","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.pmedr.2026.103571_bb0115","series-title":"Handbook of meta-Analysis","author":"Schmid","year":"2020"},{"issue":"8","key":"10.1016\/j.pmedr.2026.103571_bb0120","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s40273-015-0268-9","article-title":"The economic costs of type 2 diabetes: a global systematic review","volume":"33","author":"Seuring","year":"2015","journal-title":"Pharmacoeconomics"},{"issue":"7","key":"10.1016\/j.pmedr.2026.103571_bb0125","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.2337\/diacare.20.7.1183","article-title":"Report of the expert committee on the diagnosis and classification of diabetes Meiiitus","volume":"20","author":"The Expert Committee on the Diagnosis and Classification of Diabetes Meiiitus","year":"1997","journal-title":"Diabetes Care"},{"issue":"16","key":"10.1016\/j.pmedr.2026.103571_bb0130","article-title":"Practical methods for incorporating summary time-to-event data into meta-analysis","volume":"8","author":"Tierney","year":"2007","journal-title":"Trials"},{"issue":"2","key":"10.1016\/j.pmedr.2026.103571_bb0135","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3349\/ymj.2009.50.2.195","article-title":"An evaluation of glucose tolerance in essential hypertension","volume":"50","author":"Tugrul","year":"2009","journal-title":"Yonsei Med. J."},{"issue":"Suppl. 2","key":"10.1016\/j.pmedr.2026.103571_bb0140","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2337\/dcS15-3000","article-title":"Preventing diabetes: early versus late preventive interventions","volume":"39","author":"Tuomilehto","year":"2016","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.pmedr.2026.103571_bb0145","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1007\/s00592-020-01559-9","article-title":"Metformin use in prediabetes: is earlier intervention better?","volume":"57","author":"Warrilow","year":"2020","journal-title":"Acta Diabetol."},{"issue":"11","key":"10.1016\/j.pmedr.2026.103571_bb0150","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.3390\/nu9111273","article-title":"Prevalence of pre-diabetes across ethnicities: a review of impaired fasting glucose (IFG) and impaired glucose tolerance (IGT) for classification of Dysglycaemia","volume":"9","author":"Yip","year":"2017","journal-title":"Nutrients"}],"container-title":["Preventive Medicine Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211335526001993?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211335526001993?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T07:27:38Z","timestamp":1787124458000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211335526001993"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":30,"alternative-id":["S2211335526001993"],"URL":"https:\/\/doi.org\/10.1016\/j.pmedr.2026.103571","relation":{},"ISSN":["2211-3355"],"issn-type":[{"value":"2211-3355","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Two-hour glucose reductions and baseline levels for effective prevention of type 2 diabetes in individuals with impaired glucose tolerance: An evidence synthesis and meta-regression analysis","name":"articletitle","label":"Article Title"},{"value":"Preventive Medicine Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pmedr.2026.103571","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"103571"}}